Overexpression of the programmed cell death ligand 1 (PD-L1) in HCC inhibits the proliferation and activation of T cells, and blocking the PD-1/PD-L1 interaction can enhance immune normalization and the antitumor response (44–47). This evidence concerns the gene CD274 and hepatocellular carcinoma.